HROW
Harrow Health, Inc.
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$44.45-4.72%
Price as of Jul 20, 2026
HROW valuation
Harrow Health, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 25.22x
- P/E 2026E
- 33.21x
- P/E 2027E
- 15.66x
- P/E 2028E
- 9.86x
- P/S forward
- 3.75x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 57.72x
- Price / sales
- 6.17x
- Price / cash flow
- 108.98x
Enterprise value
- Enterprise value
- $1.9B
- EV / sales
- 6.93x
- EV / EBITDA
- 59.19x
- EV / EBIT
- 66.24x
- Market cap
- $1.7B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.